Liver Failure (Hepatic Insufficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Liver Failure clinical trial market research report provides an overview of the Liver Failure (Hepatic Insufficiency) clinical trials scenario and top-line data relating to the clinical trials on Liver Failure (Hepatic Insufficiency). It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Liver Failure Clinical Trials Market by Geography
The key regions in the Liver Failure clinical trials market are Asia-Pacific, North America, Europe, Middle East & Africa, and South & Central America. The APAC had the largest number of clinical trials conducted closely followed by North America.
In a country-wise analysis, as of October 2022, the US has the highest number of Liver Failure (Hepatic Insufficiency) clinical trials, followed by China, India, Germany, Japan, the UK, Belgium, Spain, Slovakia, and France.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, The United States has the highest proportion of Liver Failure (Hepatic Insufficiency) to Gastrointestinal clinical trials as of October 2022. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of Liver Failure (Hepatic Insufficiency) to Gastrointestinal clinical trials as of October 2022. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Liver Failure Clinical Trials Analysis by Regions
For more regional insights into the Liver Failure clinical trials market, download a free report sample
Liver Failure Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Liver Failure clinical trials market are institution, company, and the government. Out of them, company dominates the market.
Liver Failure Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the Liver Failure clinical trials market, download a free report sample
Liver Failure Clinical Trials Market - Competitive Landscape
The leading sponsors in the Liver Failure clinical trials market are Pfizer Inc, Merck & Co Inc, Novartis AG, Takeda Pharmaceutical Co Ltd, AstraZeneca Plc, Bristol-Myers Squibb Co, Eli Lilly and Co, GSK plc, Histogen Inc, and Johnson & Johnson. Out of them, Pfizer Inc has conducted the highest number of Liver Failure clinical trials.
Liver Failure Clinical Trials Market Analysis by Sponsors
To know more about the leading sponsors in the Liver Failure clinical trials market, download a free report sample
Liver Failure Clinical Trials Market Report Overview
Key Regions | Middle East & Africa, Asia-Pacific, Europe, North America, and South & Central America |
Key Countries | The US, China, India, Germany, Japan, The UK, Belgium, Spain, Slovakia, and France |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Pfizer Inc, Merck & Co Inc, Novartis AG, Takeda Pharmaceutical Co Ltd, AstraZeneca Plc, Bristol-Myers Squibb Co, Eli Lilly and Co, GSK plc, Histogen Inc, and Johnson & Johnson |
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended, and Withdrawn) with the reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Merck & Co Inc
Novartis AG
Takeda Pharmaceutical Co Ltd
AstraZeneca Plc
Bristol-Myers Squibb Co
Eli Lilly and Co
GSK plc
Histogen Inc
Johnson & Johnson
Table of Contents
Frequently asked questions
-
What are the key regions in the Liver Failure clinical trials market?
The key regions in the Liver Failure clinical trials market are the Middle East & Africa, Asia-Pacific, Europe, North America, and South & Central America.
-
What are the key countries in the Liver Failure clinical trials market?
The key countries in the Liver Failure clinical trials market are the US, China, India, Germany, Japan, The UK, Belgium, Spain, Slovakia, and France.
-
What are the key sponsor types in the Liver Failure clinical trials market?
The key sponsor types in the Liver Failure clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Liver Failure clinical trials market?
The leading sponsors in the Liver Failure clinical trials market are Pfizer Inc, Merck & Co Inc, Novartis AG, Takeda Pharmaceutical Co Ltd, AstraZeneca Plc, Bristol-Myers Squibb Co, Eli Lilly and Co, GSK plc, Histogen Inc, and Johnson & Johnson.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Gastrointestinal reports

